IP Library › Granted Patent US 9,150,918
Granted Patent B2
US 9,150,918 · App. 14/618,311 · Granted Oct 6, 2015

Identifying modified bases using hemi-natural nucleic acids

Inventors: Stephen Turner (Seattle, WA); Jonas Korlach (Camas, WA)
Assignee: Pacific Biosciences of California, Inc.
C12Q1/6874C12Q1/68C12Q1/6869G01N27/447G01N33/48721
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,150,918
App. No.
14/618,311
Granted
Oct 6, 2015
Kind
B2
Abstract

Methods, compositions, and systems are provided for characterization of modified nucleic acids. Methods are provided for sequencing hemi-natural nucleic acids such as hemi-genomic DNA, having two complementary strands, one a natural sequence and the other a synthetic sequence. The identification of modified bases can be enhanced by comparing the sequencing information from the natural sequence, which has, for example, natural base modifications, with the synthetic sequence, which typically has no base modifications. The presence and identity of a modified base can be determined by monitoring kinetics, for example the kinetics of polymer meditated nucleic acid synthesis.

Claims (29)

1. A method for single molecule sequencing and base modification detection of a nucleic acid fragment from an organism comprising:

providing a natural nucleic acid fragment from an organism;

forming a synthetic nucleic acid strand complementary to the natural nucleic acid fragment, thereby producing a template nucleic acid comprising a double-stranded portion and at least one hairpin loop connecting the two complementary strands, wherein one strand of the double stranded portion has the natural nucleic acid fragment from the organism, and the complementary strand is the synthetic nucleic acid strand complimentary to the natural nucleic acid fragment from the organism having only the four canonical bases, the four canonical bases being either (A, G, C and T) or (A, G, C and U);

carrying out single molecule sequencing to obtain sequencing information whereby the sequencing information from the strand comprising the natural sequence is compared with the sequencing information of the strand comprising the synthetic sequence to determine the presence of modified bases in the nucleic acid fragment from the organism.

2. The method of claim 1 wherein the double-stranded template nucleic acid comprises hemi-genomic DNA.

3. The method of claim 1 wherein the single molecule sequencing comprises polymerase-mediated nucleic acid synthesis.

4. The method of claim 1 wherein the double-stranded template comprises a circular molecule having hairpin loops on each end of a double-stranded portion.

5. The method of claim 4 wherein the sequencing proceeds around the circular molecule at least twice.

6. The method of claim 1 wherein the single molecule sequencing comprises nanopore sequencing.

7. The method of claim 1 wherein the sequencing information comprises kinetic information.

8. The method of claim 3 wherein the sequencing information comprises kinetic information related to polymerase mediated nucleic acid synthesis.

9. The method of claim 1 wherein the double-stranded template nucleic acid has a hairpin loop at one end of the double stranded portion, and either a 5′ or a 3′ overhang at the other end of the double stranded portion.

10. The method of claim 1 wherein the modified bases comprise methylated bases.

11. The method of claim 1 wherein the modified bases comprise one or more of 5-methylcytosine, N6-methyladenosine, N3-methyladenosine, N7-methylguanosine, 5-hydroxymethylcytosine, pseudouridine, thiouridine, isoguanosine, isocytosine, dihydrouridine, queuosine, wyosine, inosine, triazole, diaminopurine, β-D-glucopyranosyloxymethyluracil, 8-oxoguanosine, or 2′-O-methyl adenosine,2′-O-methyl cytidine, 2′-O-methyl guanosine, or 2′-O-methyl uridine.

12. The method of claim 1 comprising:

providing a substrate having an upper solution above the substrate and a lower solution below the substrate, the substrate comprising a nanopore connecting the upper solution and lower solution, the nanopore sized to pass a single stranded nucleic acid;

providing a voltage across the nanopore to produce a measurable current flow through the nanopore;

controlling the rate of translation of a single stranded portion of the template nucleic acid through the nanopore with a processive enzyme associated with the template nucleic acid;

measuring the current through the nanopore over time as it is translated through the nanopore; and

determining the sequence of a portion of the template nucleic acid as it translates through the nanopore using the measured current over time;

wherein both the natural nucleic acid sequence and the synthetic nucleic acid sequences are translated through the nanopore.

13. The method of claim 12 wherein the processive enzyme comprises polymerase, exonuclease, or helicase activity.

14. The method of claim 12 wherein the processive enzyme comprises a DNA polymerase.

15. The method of claim 12 wherein the processive enzyme comprises a helicase.

16. The method of claim 12 wherein the template nucleic acid is sequenced multiple times.

17. The method of claim 12 wherein the double-stranded template nucleic acid comprises hemi-genomic DNA.

18. The method of claim 12 wherein the sequencing information comprises kinetic information.

19. The method of claim 18 wherein the sequencing information comprises kinetic information related to polymerase mediated nucleic acid synthesis.

20. The method of claim 12 wherein the modified bases comprise methylated bases.

Continuity (3)
Continuation 13914361 · Jun 10, 2013
Provisional Application 61657583 · Jun 8, 2012
Related Publication 20150167075A1 · Jun 18, 2015